Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Colorectal Neoplasms 26Pancreatic Neoplasms 11Stomach Neoplasms 10Rectal Neoplasms 10Colonic Neoplasms 10Esophageal Neoplasms 8Adenocarcinoma Of Esophagus 8Neoplasm Metastasis 6Urinary Bladder Neoplasms 5Neoplasms 5Cholangiocarcinoma 5Carcinoma, Non-Small-Cell Lung 5Adenocarcinoma 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Squamous Cell Carcinoma of Head and Neck 3Esophageal Squamous Cell Carcinoma 3Endometrial Neoplasms 3Carcinoma, Hepatocellular 3Ovarian Neoplasms 2Melanoma 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Carcinoma 2Biliary Tract Neoplasms 2Uterine Cervical Neoplasms 1Urothelial Carcinoma of the Bladder 1Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 5Specimen Handling 4Nivolumab 3ulixertinib 2dabrafenib 2binimetinib 2Surveys and Questionnaires 2Sunitinib 2Ipilimumab 2Immunoglobulin G 2Disulfides 2Cetuximab 2CTLA-4 Antigen 2Biopsy 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1temsirolimus 1selpercatinib 1sapanisertib 1repotrectinib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1gallium Ga 68 dotatate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × Fluorouracil × 30 days × Clear all
NCT05355701 2026-05-14

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Pfizer

Phase 1 Recruiting
267 enrolled
CNSDermatologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Melanoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡